AURA — AURA BIOSCIENCES INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 157 家机构在其最新 13F 申报中持有 AURA(AURA BIOSCIENCES INC),合计申报市值 $690.83M,对应 97.58M 股。按股数计算较上季度增持 38.0%(+16.99M 股),申报市值环比上升 47.1%。持仓集中度较高:前五大持有人占申报市值的 34.6%,前十大的集中度为 55.6%。
与上一季度相比,40 家新建仓位、59 家加仓、32 家减仓、15 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
AURA BIOSCIENCES INC(AURA)的主要机构持有人包括 TCG Crossover Management, LLC、MONTANOVA CAPITAL, LLC、Frazier Life Sciences Management, L.P.,按 13F 申报市值在本页 243 家持有人中排名居前。
AURA 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 98 | 31.18M | $196.59M | +14.2% |
| Q2 2026 | 157 | 97.58M | $690.83M | +38.0% |
| Q1 2026 | 132 | 52.91M | $351.13M | +1.5% |
| Q4 2025 | 121 | 51.58M | $278.74M | -0.8% |
| Q3 2025 | 111 | 52.59M | $322.06M | +1.5% |
| Q2 2025 | 107 | 51.57M | $319.69M | +11.2% |
| Q1 2025 | 93 | 40.48M | $232.19M | +3.9% |
| Q4 2024 | 94 | 40.15M | $325.50M | +6.9% |
表内 8 个季度中,机构持股合计减少 22%(Q4 2024 → Q3 2026);单季变动最大的是 Q2 2026(+38.0%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 5.42M | $34.06M | 0.00% | 增持 | |
| 3.95M | $24.82M | 0.00% | 减持 | |
| 3.81M | $23.91M | 1.10% | 增持 | |
| 3.04M | $19.09M | 15.07% | 持有 | |
| 2.30M | $14.45M | 0.00% | 增持 | |
| 2.08M | $13.85M | 0.00% | 持有 | |
| 1.94M | $12.22M | 0.00% | 增持 | |
| 1.17M | $7.33M | 0.83% | 持有 | |
| 942.72K | $5.92M | 0.00% | 增持 | |
| 826.83K | $5.19M | 0.38% | 减持 | |
| 708.95K | $4.45M | 0.00% | 增持 | |
| 633.16K | $3.98M | 0.00% | 减持 | |
| 533.07K | $3.35M | 1.35% | 减持 | |
| 384.00K | $2.41M | 0.00% | 增持 | |
| 272.14K | $1.71M | 0.00% | 增持 | |
| 266.72K | $1.68M | 0.01% | 新进 | |
| 218.93K | $1.37M | 0.01% | 增持 | |
| 216.92K | $1.36M | 0.00% | 增持 | |
| 196.81K | $1.24M | 0.00% | 增持 | |
| 174.12K | $1.09M | 0.02% | 新进 | |
| 142.57K | $895.37K | 0.00% | 增持 | |
| 140.08K | $879.73K | 0.00% | 减持 | |
| 138.06K | $866.99K | 0.00% | 增持 | |
| 102.92K | $646.33K | 0.00% | 增持 | |
| 100.72K | $632.49K | 0.00% | 增持 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
Q1 2026 — 25 家基金
Q4 2025 — 25 家基金
Q3 2025 — 25 家基金
Q2 2025 — 25 家基金
新建仓(Q2 2026)
- TCG Crossover Management, LLC 9.53M 股 · $67.69M
- FCPM III SERVICES B.V. 4.05M 股 · $28.78M
- ORBIMED ADVISORS LLC 3.33M 股 · $23.67M
- Jupiter Topco LLC 2.50M 股 · $17.79M
- RA CAPITAL MANAGEMENT, L.P. 2.50M 股 · $17.75M
- GEODE CAPITAL MANAGEMENT, LLC 1.75M 股 · $12.46M
- EcoR1 Capital, LLC 1.67M 股 · $11.83M
- Redmile Group, LLC 1.67M 股 · $11.83M
- Trails Edge Capital Partners, LP 1.44M 股 · $10.25M
- Foresite Capital Management VI LLC 1.33M 股 · $9.47M
- Woodline Partners LP 1.21M 股 · $8.59M
- Bellevue Group AG 1.17M 股 · $8.28M
完全清仓(较上季)
- Matrix Capital Management Company, LP 卖出 6.92M 股 · $46.31M
- STATE STREET CORP 卖出 964.67K 股 · $6.45M
- Maven Securities LTD 卖出 50.00K 股 · $334.50K
- AMERICAN CENTURY COMPANIES INC 卖出 48.32K 股 · $323.28K
- Brevan Howard Capital Management LP 卖出 29.75K 股 · $199.00K
- Susquehanna Portfolio Strategies, LLC 卖出 28.73K 股 · $192.20K
- EntryPoint Capital, LLC 卖出 26.30K 股 · $175.95K
- 49 WEALTH MANAGEMENT, LLC 卖出 21.70K 股 · $145.20K
- Trexquant Investment LP 卖出 21.00K 股 · $140.48K
- BRIDGEWAY CAPITAL MANAGEMENT, LLC 卖出 16.28K 股 · $108.89K
- CWM, LLC 卖出 4.02K 股 · $26.88K
- GROUP ONE TRADING LLC 卖出 1.50K 股 · $10.04K
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | 5.42M | 4.71M | 3.59M | 3.56M | 3.41M | 3.10M | 3.54M | 3.55M | 3.16M | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.95M | 4.10M | 2.24M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Nantahala Capital Management, LLC | 3.81M | 2.95M | 2.12M | 2.12M | 2.12M | 2.12M | 1.27M | 1.27M | 1.27M | 1.27M | 1.32M | 1.32M | 743.89K | — | — | — | — | — | — | — |
| Medicxi Ventures Management (Jersey) Ltd | 3.04M | 3.04M | 3.04M | 3.04M | 3.04M | 3.04M | 3.04M | 3.04M | 3.04M | 3.04M | 3.04M | 3.04M | 3.04M | — | — | — | — | — | — | — |
| STATE STREET CORP | 2.30M | — | 964.67K | 926.53K | 878.87K | 856.19K | 793.01K | 801.82K | 754.80K | 727.96K | 569.80K | 506.26K | 457.36K | — | — | — | — | — | — | — |
| Franklin Resources | 2.08M | 2.07M | 2.07M | 2.20M | 2.20M | 2.34M | 2.21M | 1.72M | 1.67M | 1.45M | 1.45M | 600.12K | — | — | — | — | — | — | — | — |
| Geode Capital Management | 1.94M | 1.75M | 1.31M | 1.26M | 1.26M | 929.97K | 1.03M | 1.01M | 1.01M | 969.45K | 781.19K | 676.13K | 526.44K | 499.60K | 457.91K | 300.47K | 289.31K | 207.29K | 105.33K | 102.08K |
| Vivo Capital, LLC | 1.17M | 1.17M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 942.72K | 871.34K | 391.33K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| LEVIN CAPITAL STRATEGIES, L.P. | 826.83K | 838.07K | 941.40K | 1.04M | 1.63M | 1.50M | 1.36M | 1.25M | 50.00K | 327.47K | 111.20K | 100.00K | 81.09K | — | — | — | — | — | — | — |
| DIMENSIONAL FUND ADVISORS LP | 708.95K | 618.89K | 558.16K | 517.92K | 497.27K | 456.16K | 405.93K | 365.82K | 292.76K | 250.38K | 208.66K | 177.72K | 111.54K | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 633.16K | 637.20K | 397.16K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Regency Capital Management Inc.\DE | 533.07K | 540.39K | 532.50K | 538.58K | 612.69K | 665.88K | 749.48K | 609.42K | 667.31K | 765.05K | 785.14K | 704.97K | 526.98K | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | 384.00K | 255.33K | 2.89K | 8.14K | 3.47K | 1.54K | 29.64K | 31.55K | 101.22K | 230.45K | 294.65K | 357.04K | 358.56K | 358.64K | 356.85K | 728.40K | 603.76K | 603.47K | 494.11K | 471.30K |
| Qube Research & Technologies Ltd | 272.14K | 109.56K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| HRT FINANCIAL LP | 266.72K | — | — | — | — | 56.53K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Jump Financial, LLC | 218.93K | 73.00K | — | — | — | — | — | — | — | — | 12.40K | — | — | — | — | — | — | — | — | — |
| Quantinno Capital Management LP | 216.92K | 130.66K | 91.08K | 36.38K | 44.64K | 21.87K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 196.81K | 174.69K | 224.04K | 218.41K | 178.50K | 150.29K | 99.45K | 163.03K | 183.99K | 82.84K | 86.86K | 82.77K | 21.08K | 80.67K | 72.59K | 64.60K | 55.15K | 54.54K | 1.11K | 534 |
| Y-Intercept (Hong Kong) Ltd | 174.12K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold AURA?
As of 2026-Q2, 157 institutional funds reported holding AURA (AURA BIOSCIENCES INC) in SEC 13F filings, with a combined reported value of $690.83M.
How many shares of AURA do institutions own?
13F filers reported 97.58M shares of AURA, worth $690.83M in aggregate at the end of 2026-Q2.
Is institutional ownership of AURA rising or falling?
Share counts moved +38.0% versus the prior quarter — accumulation.
Who are the top institutional holders of AURA?
The largest 13F holders are TCG Crossover Management, LLC, MONTANOVA CAPITAL, LLC, Frazier Life Sciences Management, L.P., Matrix Capital Management Company, LP, Long Focus Capital Management, LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of AURA BIOSCIENCES INC?
The major shareholders of AURA BIOSCIENCES INC (AURA) by reported 13F value are TCG Crossover Management, LLC, MONTANOVA CAPITAL, LLC, Frazier Life Sciences Management, L.P., Matrix Capital Management Company, LP, Long Focus Capital Management, LLC, among 243 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.